Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0037315 (sleep apnea)
 8,000 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Sleep disorders are common and underrecognized in patients at all stages of chronic kidney disease. They include sleep apnea, insomnia, excessive sleepiness, restless legs syndrome and periodic limb movement disorder. They can be related to underlying uremia or comorbidities. Sleep disorders can affect the quality of life, and some are associated with increased morbidity and mortality. Clinical assessment, polysomnography and other standardized assessments are required for diagnosis. Therapeutic approaches include improvement in uremia management, treatment of comorbidities or specific interventions directed at individual sleep disorders. Diagnosis and treatment of sleep disorders in this population may improve quality of life and patient survival.
 ...
PMID:Sleep disorders over the full range of chronic kidney disease. 2122 83

Sleep disorders are common in patients with end-stage renal disease. Daytime sleepiness, restless legs syndrome, periodic limb movement disorder, insomnia, sleep apnea syndrome are the most disturbances. Usually, sleep-related complaints are attributed to uremia because of similar symptoms, and this may cause to delayed diagnosis. Sleep disorders are negative effect on quality of life and compliance to treatment of patients as well as cause increased mortality and morbidity. Therefore, sleep disorders should be evaluated as a different clinical entity in patients with chronic kidney failure or receiving renal replacement therapy. In this article, we aimed to review of etiology, pathogenesis and treatment of common sleep disorders in end-stage renal failure in sight of related literature information.
 ...
PMID:[Sleep disorders in end-stage renal failure]. 2134 Nov 24


<< Previous 1 2